Go Pro
→ Before Anthropic becomes impossible to ignore... (From The Oxford Club) (Ad)tc pixel
Emily Bodnar

Emily Bodnar Analyst Performance

Biotech Equity Research Analyst at HC Wainwright

Emily Bodnar is a stock analyst at HC Wainwright in the healthcare sector, covering 35 publicly traded companies. Over the past year, Emily Bodnar has issued 81 stock ratings, including strong buy, buy, and hold recommendations. While full access to Emily Bodnar's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Emily Bodnar's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
141 Last 1 Years
Buy Recommendations
92.14% 129 Buy Ratings
Companies Covered
35 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.7%1 ratings
Buy91.4%128 ratings
Hold7.9%11 ratings
Sell0.0%0 ratings

Out of 140 total stock ratings issued by Emily Bodnar at HC Wainwright, the majority (91.4%) have been Buy recommendations, followed by 7.9% Hold and 0.7% Strong Buy.

Best & Worst Calls

Exchange Coverage

ExchangePercentageCount
NASDAQ
97.1% of companies on NASDAQ
34 companies
NYSE
2.9% of companies on NYSE
1 company

Emily Bodnar, an analyst at HC Wainwright, currently covers 35 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
35 companies		100.0%

Emily Bodnar of HC Wainwright specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
32 companies		91.4%
HEALTHCARE EQUIPMENT & SUPPLIES
2 companies		5.7%
PHARMACEUTICALS
1 company		2.9%

About Emily Bodnar

Emily Bodnar is a Vice President of Equity Research at H.C. Wainwright who joined the firm in January 2022. Ms. Bodnar’s research focuses on the Biotechnology and Women’s Healthcare industries. Prior to joining H.C. Wainwright, Ms. Bodnar was a Senior Equity Research Associate at Cantor Fitzgerald assisting in coverage of small/mid and large-cap biotechnology companies. Ms. Bodnar also worked as an Equity Research Associate at Berenberg Capital Markets assisting in coverage of small/mid-cap biotechnology companies. Ms. Bodnar graduated summa cum laude from Binghamton University where she received a Bachelor of Science. Ms. Bodnar has also taken several Biology and Immunology courses from Johns Hopkins University and Rice University.
Follow on LinkedIn

Emily Bodnar's Ratings History at HC Wainwright

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
Export
CompanyReport DateActionReport Date Price12-Month
Price Target		Rating12-Month
Price & ROI		Details
TRAX
First Tracks Biotherapeutics
9/3/2026Reiterated Rating$45.28$57.00Buy
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
9/1/2026Reiterated Rating$54.66$78.00Buy
ODTX
Odyssey Therapeutics
8/27/2026Initiated Coverage$25.62$44.00Buy
ODTX
Odyssey Therapeutics
8/27/2026Initiated Coverage$25.98$44.00Buy
NextCure, Inc. stock logo
NXTC
NextCure
8/13/2026Reiterated Rating$8.17Buy
TRAX
First Tracks Biotherapeutics
8/13/2026Boost Price Target$46.13$57.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
8/11/2026Lower Price Target$11.94$36.00Buy
Nkarta, Inc. stock logo
NKTX
Nkarta
8/11/2026Lower Price Target$2.46$14.00Buy
Agenus Inc. stock logo
AGEN
Agenus
8/11/2026Reiterated Rating$7.00$25.00Buy
Hemab Therapeutics Holdings, Inc. stock logo
COAG
Hemab Therapeutics
8/11/2026Boost Price Target$51.32$60.00Buy
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
8/6/2026Lower Price Target$34.06$42.00Buy
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
8/4/2026Reiterated Rating$46.17$78.00Buy
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
8/3/2026Reiterated Rating$1.90$10.00Buy
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
7/30/2026Boost Price Target$33.02$55.00Buy
NovoCure Limited stock logo
NVCR
NovoCure
7/24/2026Set Price Target$19.42$32.00
NovoCure Limited stock logo
NVCR
NovoCure
7/23/2026Boost Price Target$19.79$52.00Buy
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
7/21/2026Lower Price Target$37.10$52.00Buy
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
7/20/2026Boost Price Target$27.46$45.00Buy
Hemab Therapeutics Holdings, Inc. stock logo
COAG
Hemab Therapeutics
7/13/2026Boost Price Target$38.03$52.00Buy
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
7/13/2026Boost Price Target$57.12$77.00Buy
Agenus Inc. stock logo
AGEN
Agenus
7/13/2026Boost Price Target$6.68$30.00Buy
TRAX
First Tracks Biotherapeutics
7/10/2026Boost Price Target$32.40$44.00Buy
TRAX
First Tracks Biotherapeutics
7/8/2026Reiterated Rating$19.82$30.00Buy
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
7/6/2026Reiterated Rating$55.46$70.00Buy
Hemab Therapeutics Holdings, Inc. stock logo
COAG
Hemab Therapeutics
6/26/2026Reiterated Rating$31.42$40.00Buy
NovoCure Limited stock logo
NVCR
NovoCure
6/18/2026Reiterated Rating$14.68$46.00Buy
Hemab Therapeutics Holdings, Inc. stock logo
COAG
Hemab Therapeutics
6/17/2026Initiated Coverage$25.51$40.00Buy
Hemab Therapeutics Holdings, Inc. stock logo
COAG
Hemab Therapeutics
6/17/2026Initiated Coverage$26.45$40.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
6/15/2026Reiterated Rating$3.33$10.00Buy
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
5/27/2026Reiterated Rating$39.76$70.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
5/22/2026Reiterated Rating$14.06Buy
MiNK Therapeutics, Inc. stock logo
INKT
MiNK Therapeutics
5/18/2026Reiterated Rating$10.48$35.00Buy
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
5/14/2026Boost Price Target$1.59$10.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
5/12/2026Boost Price Target$3.60$10.00Buy
Artiva Biotherapeutics, Inc. stock logo
ARTV
Artiva Biotherapeutics
5/8/2026Boost Price Target$11.85$35.00Buy
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
5/6/2026Boost Price Target$39.69$70.00Buy
TRAX
First Tracks Biotherapeutics
4/28/2026Initiated Coverage$18.10$30.00Buy
TRAX
First Tracks Biotherapeutics
4/28/2026Upgrade$20.05$30.00Strong-Buy
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
4/20/2026Lower Price Target$27.11$50.00Buy
MiNK Therapeutics, Inc. stock logo
INKT
MiNK Therapeutics
4/1/2026Reiterated Rating$10.53$35.00Buy
This free guide explains options the way they should be taught (Ad)

Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before they ever place a trade. This free guide from Base Camp Trading takes a different approach, starting with the basics and showing you exactly how options work, why traders use them, and how they fit into a simple trading plan.tc pixel

Claim your free options guide and start building real trading knowledge
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
3/30/2026Reiterated Rating$57.40$66.00Buy
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
3/26/2026Boost Price Target$5.42$25.00Buy
Purple Biotech Ltd. Sponsored ADR stock logo
PPBT
Purple Biotech
3/13/2026Lower Price Target$4.10$30.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
3/10/2026Lower Price Target$3.84$7.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
3/9/2026Lower Price Target$17.25$38.00Buy
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
3/4/2026Lower Price Target$3.93$7.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
3/4/2026Boost Price Target$52.83$66.00Buy
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
3/2/2026Reiterated Rating$20.36$32.00Buy
NovoCure Limited stock logo
NVCR
NovoCure
2/26/2026Boost Price Target$13.11$49.00Buy
Arcellx, Inc. stock logo
ACLX
Arcellx
2/23/2026Downgrade$113.84$115.00Neutral
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
2/17/2026Initiated Coverage$1.40$9.00Buy
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
2/17/2026Initiated Coverage$1.51$9.00Buy
NovoCure Limited stock logo
NVCR
NovoCure
2/12/2026Boost Price Target$10.50$47.00Buy
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
2/12/2026Boost Price Target$28.71$65.00Buy
Arcellx, Inc. stock logo
ACLX
Arcellx
2/4/2026Reiterated Rating$68.83$115.00Buy
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
1/20/2026Downgrade$57.52$58.00Neutral
NovoCure Limited stock logo
NVCR
NovoCure
1/13/2026Lower Price Target$14.18$39.00Buy
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
1/8/2026Downgrade$13.73$14.00Neutral
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
12/24/2025Boost Price Target$28.85$62.00Buy
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
12/19/2025Reiterated Rating$34.72$47.00Buy
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
12/12/2025Boost Price Target$22.39$32.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
12/11/2025Boost Price Target$30.68$45.00Buy
Acrivon Therapeutics, Inc. stock logo
ACRV
Acrivon Therapeutics
11/25/2025Reiterated Rating$2.36$19.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
11/24/2025Lower Price Target$39.61$51.00Buy
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
11/20/2025Lower Price Target$22.34$48.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
11/18/2025Boost Price Target$19.85$36.00Buy
Artiva Biotherapeutics, Inc. stock logo
ARTV
Artiva Biotherapeutics
11/12/2025Boost Price Target$3.65$15.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
11/11/2025Lower Price Target$33.98$52.00Buy
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
11/7/2025Lower Price Target$4.05$9.00Buy
Context Therapeutics Inc. stock logo
CNTX
Context Therapeutics
11/6/2025Boost Price Target$1.13$5.00Buy
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
11/5/2025Upgrade$8.09$18.00Buy
NovoCure Limited stock logo
NVCR
NovoCure
10/30/2025Boost Price Target$12.79$42.00Buy
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
10/29/2025Boost Price Target$19.89$28.00Buy
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
10/27/2025Boost Price Target$30.11$72.00Buy
Agenus Inc. stock logo
AGEN
Agenus
10/20/2025Reiterated Rating$3.88Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
10/20/2025Reiterated Rating$9.36$28.00Buy
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
10/14/2025Initiated Coverage$1.68$12.00Buy
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
10/6/2025Initiated Coverage$36.71$60.00Buy
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
10/6/2025Initiated Coverage$36.76$60.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
9/30/2025Boost Price Target$23.27$59.00Buy
IO Biotech, Inc. stock logo
IOBT
IO Biotech
9/29/2025Downgrade$0.35Neutral
Agenus Inc. stock logo
AGEN
Agenus
9/10/2025Reiterated Rating$5.07$23.00Buy
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
9/4/2025Reiterated Rating$35.90$56.00Buy
Agenus Inc. stock logo
AGEN
Agenus
8/28/2025Reiterated Rating$4.54$23.00Buy
MiNK Therapeutics, Inc. stock logo
INKT
MiNK Therapeutics
8/15/2025Upgrade$15.32$35.00Buy
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
8/13/2025Reiterated Rating$14.50$36.00Buy
Femasys Inc. stock logo
FEMY
Femasys
8/11/2025Lower Price Target$16.94$160.00Buy
Context Therapeutics Inc. stock logo
CNTX
Context Therapeutics
8/7/2025Lower Price Target$0.70$4.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
7/22/2025Lower Price Target$2.70$9.00Buy
MiNK Therapeutics, Inc. stock logo
INKT
MiNK Therapeutics
7/15/2025Downgrade$29.53$35.00Neutral
Trump's new AI tirade hurting GOP? (Ad)

President Trump says AI will become the greatest economic development engine in history, dismissing fears of disruption. Meanwhile, the GOP is working to ease AI concerns ahead of the midterm elections. Investor Whitney Tilson sees this growing divide as the start of an 'AI Civil War,' set to unfold in less than 100 days with major implications for markets.tc pixel

Read Whitney Tilson's full free AI Civil War analysis now
Jasper Therapeutics, Inc. stock logo
JSPR
Jasper Therapeutics
7/7/2025Lower Price Target$3.04$20.00Buy
NextCure, Inc. stock logo
NXTC
NextCure
7/1/2025Reiterated Rating$5.52$36.00Buy
Femasys Inc. stock logo
FEMY
Femasys
6/25/2025Reiterated Rating$19.00$240.00Buy
Arcellx, Inc. stock logo
ACLX
Arcellx
6/16/2025Reiterated Rating$66.00$115.00Buy
Femasys Inc. stock logo
FEMY
Femasys
6/11/2025Reiterated Rating$16.74$240.00Buy
Agenus Inc. stock logo
AGEN
Agenus
6/4/2025Upgrade$5.00$25.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
5/14/2025Initiated Coverage$1.80$10.00Buy
Agenus Inc. stock logo
AGEN
Agenus
5/13/2025Reiterated Rating$3.50Neutral
Femasys Inc. stock logo
FEMY
Femasys
5/9/2025Lower Price Target$23.20$240.00Buy
Agenus Inc. stock logo
AGEN
Agenus
4/30/2025Reiterated Rating$3.05Neutral
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
4/28/2025Reiterated Rating$4.91$30.00Buy
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
4/24/2025Reiterated Rating$1.71$11.00Buy
Briacell Therap stock logo
BCTX
Briacell Therap
4/22/2025Reiterated Rating$48.03$320.00Buy
TransCode Therapeutics Inc. stock logo
RNAZ
TransCode Therapeutics
4/16/2025Lower Price Target$11.14$280.00Buy
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
4/9/2025Initiated Coverage$15.80$36.00Buy
IO Biotech, Inc. stock logo
IOBT
IO Biotech
4/1/2025Reiterated Rating$1.09$12.00Buy
Genelux Corporation stock logo
GNLX
Genelux
3/31/2025Reiterated Rating$3.08$30.00Buy
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
3/31/2025Reiterated Rating$0.68$8.00Buy
Femasys Inc. stock logo
FEMY
Femasys
3/28/2025Reiterated Rating$26.70$300.00Buy
Nkarta, Inc. stock logo
NKTX
Nkarta
3/27/2025Reiterated Rating$1.37$18.00Buy
Imunon, Inc. stock logo
IMNN
Imunon
3/26/2025Reiterated Rating$15.00$210.00Buy
Acrivon Therapeutics, Inc. stock logo
ACRV
Acrivon Therapeutics
3/26/2025Lower Price Target$5.39$19.00Buy
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
3/26/2025Reiterated Rating$10.86$105.00Buy
Genelux Corporation stock logo
GNLX
Genelux
3/25/2025Reiterated Rating$3.41$30.00Buy
Context Therapeutics Inc. stock logo
CNTX
Context Therapeutics
3/21/2025Reiterated Rating$0.77$5.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
3/19/2025Reiterated Rating$4.14$30.00Buy
Femasys Inc. stock logo
FEMY
Femasys
3/19/2025Boost Price Target$31.92$300.00Buy
Agenus Inc. stock logo
AGEN
Agenus
3/18/2025Reiterated Rating$1.78Neutral
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
3/18/2025Reiterated Rating$2.77$11.00Buy
MiNK Therapeutics, Inc. stock logo
INKT
MiNK Therapeutics
3/18/2025Reiterated Rating$8.06$35.00Buy
NextCure, Inc. stock logo
NXTC
NextCure
3/17/2025Reiterated Rating$8.45$36.00Buy
TransCode Therapeutics Inc. stock logo
RNAZ
TransCode Therapeutics
3/13/2025Reiterated Rating$25.34$560.00Buy
Femasys Inc. stock logo
FEMY
Femasys
3/13/2025Reiterated Rating$28.80$240.00Buy
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
3/12/2025Reiterated Rating$11.11$105.00Buy
Agenus Inc. stock logo
AGEN
Agenus
3/12/2025Reiterated Rating$2.05Neutral
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
3/11/2025Reiterated Rating$4.25$30.00Buy
Jasper Therapeutics, Inc. stock logo
JSPR
Jasper Therapeutics
3/11/2025Reiterated Rating$5.14$40.00Buy
NextCure, Inc. stock logo
NXTC
NextCure
3/7/2025Reiterated Rating$8.55$36.00Buy
IO Biotech, Inc. stock logo
IOBT
IO Biotech
3/5/2025Reiterated Rating$0.91$12.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
3/5/2025Reiterated Rating$4.18$30.00Buy
Femasys Inc. stock logo
FEMY
Femasys
2/26/2025Reiterated Rating$31.60$240.00Buy
MiNK Therapeutics, Inc. stock logo
INKT
MiNK Therapeutics
2/25/2025Boost Price Target$10.65$35.00Buy
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
2/24/2025Initiated Coverage$35.22$58.00Buy
Femasys Inc. stock logo
FEMY
Femasys
2/11/2025Reiterated Rating$25.10$240.00Buy
TransCode Therapeutics Inc. stock logo
RNAZ
TransCode Therapeutics
2/6/2025Reiterated Rating$321.02$560.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
2/3/2025Reiterated Rating$1.05$18.00Buy
Briacell Therap stock logo
BCTX
Briacell Therap
2/3/2025Boost Price Target$50.80$320.00Buy
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
1/30/2025Reiterated Rating$12.84$105.00Buy
Agenus Inc. stock logo
AGEN
Agenus
1/22/2025Reiterated Rating$3.83Neutral
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
1/14/2025Reiterated Rating$1.95Neutral
Elon Musk’s Hushed FCC Filing. Sept 25th. (Ad)

Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the largest markets in the world. James Altucher, who previously flagged Nvidia in 2008 and Bitcoin in 2013, says the filing could rival Tesla, SpaceX and xAI combined. Few investors know this filing exists, but that is expected to change quickly.tc pixel

Click here to see details on Elon Musk's newest AI filing
Jasper Therapeutics, Inc. stock logo
JSPR
Jasper Therapeutics
1/10/2025Lower Price Target$6.99$40.00Buy

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Top Stock Recommendations by Brokerage